Malignant lymphoma
Conditions
Interventions
Capsule group:Aiyu Capsule + The basic treatment of Western Medicine
control group:Kangsaidi+The basic treatment of Western Medicine
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed as B-cell non-hodgkin's malignant lymphoma by imaging and/or histopathology or cytology; 2. The patients have clinically measurable focus, such as the enlargement of spleen or lymph node, nodular or tumorous; 3. In accordance with the standards of syndrome differentiation on deficiency of Qi and poison knot; 4. Aged between 18~75 years old, both gender; 5. The counts of leukocytes and platelets in recipient blood are in normal range (+/-20%); 6. The ALT values are over 2.5 times the upper normal limit, No serious diseases of heart, liver, kidney, blood and other systems; 7. performance status(KPS) score above 60 points;survival period is longer than 3 months; 8. Volunteers, and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients have mental diseases or cannot describe the syndromes clearly; 2. With the other severe internal diseases; 3. pregnant women and lactating women; 4. Not good medication compliance in previous treatment history; 5. Be allergic to the medicine in this research; 6. Patients are in the other clinical researches.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| type-B ultrasonic;CT;MRI; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hb;RBC;WBC;PLT;karnofsky; | — |
Countries
China
Contacts
Public ContactXinyi Chen
Outcome results
None listed